At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 10 enrolled
Drug / intervention
Folic Acid Tabletdrug
Likely dose
Folic Acid Tablet 1 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Study of Serum Folate Levels in Patients With Treated With Olaparib.
In Brief
A Phase 4 clinical trial evaluating Folic Acid Tablet for Ovarian Cancer and 2 related conditions. Completed, enrolled 10 participants across 1 site.
Detailed Summary
This is a study investigating folate deficiency (lack of folic acid in the blood) in patients who take the drug olaparib to treat their advanced ovarian or breast cancer.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOvarian Cancer, Breast Cancer, Folic Acid Deficiency
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
2020202120222023202420252026
First PostedJul 2019
Enrollment StartJul 2020
Primary CompletionDec 2025
TodayJul 2026
First PostedJul 18, 2019
Enrollment StartJul 21, 2020
Primary CompletionDec 31, 2025
TodayJul 2, 2026
Enrollment to primary: 5.4 yearsPosted 7.0 years ago
Interventions
Folic Acid Tabletdrug
Folic Acid 1 mg by mouth daily